The MarketWatch News Department was not involved in the creation of this content. The Federal Trade Commission is sending more than $10.9 million to consumers harmed by a credit repair operation known ...

A large VHA real-world analysis compared GLP‑1 receptor agonists (~132,000) with sulfonylureas (>201,000), focusing on major adverse cardiovascular outcomes in type 2 diabetes. Continuous GLP‑1 ...

Dieticians are warning that GLP-1 use can lead to extreme malnutrition, manifesting in diseases like scurvy, amid findings that the vast majority of studies fail to consider patients’ eating habits.

Although one GLP-1 study made national headlines about the drug class’ potential use in addiction treatment, other research indicates GLP-1s could increase the risk of bone injuries and are less ...

New data suggest a link between using GLP-1 receptor agonists (GLP-1 RAs) and a significantly higher risk for tendon ruptures, primarily tears involving the rotator cuff, Achilles, and pectoralis ...

Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. New research suggests prolonged GLP-1 use may be linked ...

Share on Pinterest GLP-1s linked to higher osteoporosis risk but they may bring some benefits, too, new studies find. Image credit: SweetBunFactory/Getty Images A large percentage of Americans are ...

Target-trial emulation in VA EHRs constructed eight parallel new-user trials comparing GLP-1 RA initiators with SGLT-2 inhibitor initiators under two protocols: incident SUDs and SUD-related adverse ...

What began as an unexpected observation and “side effect” of some medications converged with decades of addiction neuroscience: GLP-1 receptor agonist medications like Ozempic apparently reduce ...

A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes. He didn’t use a patch. He ...